Identifying biomarkers of risk and poor prognosis in CRC
|Dr Daniel Buchananemail@example.com||+61 3 8344 1240||Personal web page|
- peripheral blood biomarkers that indicate or quantify an individual's risk for developing CRC or other cancers, specifically, risk associated SNPs and measuring DNA methylation of white blood cell DNA as a marker of cancer risk
- tumour biomarkers that indicate a relative maybe at an increased risk of developing CRC
- tumour features that are associated with a poor prognosis.
Faculty Research Themes
School Research Themes
For further information about this research, please contact the research group leader.